Hua Qu Selected Research

15-keto-13,14-dihydroprostaglandin E2

2/2021

Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hua Qu Research Topics

Disease

16	Insulin Resistance 09/2021 - 01/2013
13	Type 2 Diabetes Mellitus (MODY) 09/2021 - 01/2013
11	Inflammation (Inflammations) 01/2022 - 01/2013
6	Myocardial Infarction 07/2022 - 04/2016
6	Atherosclerosis 01/2022 - 01/2005
6	Obesity 09/2021 - 01/2013
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2005
4	Chronic Renal Insufficiency 01/2022 - 01/2020
4	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2014
4	Neoplasms (Cancer) 08/2021 - 06/2019
3	Stroke (Strokes) 01/2022 - 10/2008
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2018
3	Necrosis 01/2021 - 04/2016
3	Glucose Intolerance 09/2018 - 01/2015
3	Diabetic Cardiomyopathies 11/2017 - 01/2017
2	Peripheral Nervous System Diseases (PNS Diseases) 03/2022 - 11/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2018
2	Obstructive Sleep Apnea 01/2022 - 01/2018
2	Infarction (Infarctions) 01/2022 - 10/2008
2	Hyperkalemia 09/2021 - 01/2021
2	Hypotension (Low Blood Pressure) 09/2021 - 01/2021
2	Prediabetic State (Prediabetes) 09/2021 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 11/2016
2	Diabetic Foot 01/2021 - 01/2020
2	Hyperglycemia 01/2019 - 11/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 01/2017
2	Fibrosis (Cirrhosis) 01/2017 - 01/2017
1	Erectile Dysfunction 10/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2021
1	Acute Kidney Injury (Acute Renal Failure) 09/2021
1	Cough 06/2021
1	Virus Diseases (Viral Diseases) 06/2021
1	Pneumonia (Pneumonitis) 06/2021
1	Essential Hypertension 03/2021
1	COVID-19 03/2021
1	Dyspepsia (Indigestion) 02/2021
1	Proteinuria 01/2021
1	Female Infertility 01/2021
1	Infertility (Sterility) 01/2021

Drug/Important Bio-Agent (IBA)

11	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2015
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
7	Insulin (Novolin)FDA Link 09/2021 - 05/2015
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2014
6	Triglycerides (Triacylglycerol)IBA 01/2018 - 05/2015
5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2016
4	AlbuminsIBA 09/2021 - 11/2016
4	Hypoglycemic Agents (Hypoglycemics)IBA 03/2021 - 11/2017
3	LipidsIBA 01/2022 - 01/2016
3	SaponinsIBA 02/2021 - 01/2018
3	C-Reactive ProteinIBA 01/2021 - 01/2016
3	HDL CholesterolIBA 09/2018 - 05/2015
2	PotassiumIBA 07/2022 - 09/2021
2	astragaloside AIBA 03/2022 - 11/2021
2	CholesterolIBA 01/2022 - 01/2016
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 02/2021 - 01/2018
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2021
2	Capsules (Microcapsules)IBA 01/2021 - 04/2018
2	tetramethylpyrazineIBA 11/2020 - 04/2016
2	Cardiotonic Agents (Cardiac Stimulants)IBA 04/2020 - 06/2019
2	BufanolidesIBA 04/2020 - 06/2019
2	Anesthetics (Anesthetic Agents)IBA 04/2020 - 06/2019
2	coenzyme Q10 (CoQ10)IBA 11/2018 - 10/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 10/2018
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2018 - 01/2016
2	AdipokinesIBA 01/2018 - 05/2015
2	CateninsIBA 11/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 09/2017 - 10/2016
2	CytokinesIBA 02/2017 - 01/2014
2	Alanine Transaminase (SGPT)IBA 10/2016 - 01/2016
2	ORALIT (ORS)IBA 01/2016 - 01/2014
1	Phosphodiesterase 5 InhibitorsIBA 10/2022
1	AntioxidantsIBA 10/2022
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Uremic ToxinsIBA 01/2022
1	Sulfates (Sulfates, Inorganic)IBA 01/2022
1	Capsaicin (Zostrix)FDA Link 01/2022
1	IndicanIBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	zedoarondiolIBA 01/2022
1	NAD (NADH)IBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 10/2021
1	CreatinineIBA 09/2021
1	SecretagoginsIBA 09/2021
1	amsonic acid (DAS)IBA 08/2021
1	huashi baiduIBA 06/2021
1	Nonprescription Drugs (Patent Medicines)IBA 03/2021
1	15-keto-13,14-dihydroprostaglandin E2IBA 02/2021
1	MotilinIBA 02/2021
1	GastrinsIBA 02/2021
1	Dinoprostone (PGE2)FDA Link 02/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2021
1	alpha-glycerophosphoric acid (sodium glycerophosphate)IBA 01/2021

Therapy/Procedure

9	Therapeutics 10/2022 - 01/2012
2	Percutaneous Coronary Intervention 01/2021 - 01/2018
1	Patient Readmission 01/2021